NEW YORK (GenomeWeb News) — Synthetic Genomics and the Asian Center for Genome Technology plan to sequence and analyze the genome of the oil palm, and ACGT’s parent company has made an undisclosed equity investment in SG, SG said today.
ACGT, based in Kuala Lumpur, is owned by an oil palm plantation, Asiatic Development Berhad, which is listed on the Malaysian Stock Exchange.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.